Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation

Cancer Chemotherapy and Pharmacology
Feng NiZhi-Gang Zhang

Abstract

The mainstay of treatment for advanced bladder cancer (BC) is cisplatin (CDDP)-based systematic chemotherapy. However, acquired chemoresistance induced by as yet unidentified mechanisms is encountered frequently and often results in treatment failure and disease progression. The present study was designed to elucidate the expression and potential role of the gene associated with retinoid-interferon-induced mortality-19 (GRIM19) in the pathogenesis of CDDP resistance in BC. RT-qPCR and immunoblotting were employed to evaluate the expression profile of GRIM19 in clinical BC samples and in different BC cells. Using cell viability assay, apoptotic ELISA, xenografts mouse model, and Transwell assay, the effects of GRIM19 inhibition or GRIM19 overexpression on CDDP resistance were determined in different BC cells. Lastly, using co-immunoprecipitation, we provided the molecular evidence for the interaction between GRIM19 and Bcl-xL. Expression levels of GRIM19 were significantly down-regulated in recurrent BC specimens, and in experimentally induced CDDP-resistant BC cells. Functionally, overexpression of the exogenous GRIM19 potentiated CDDP sensitivity and suppressed the survival and invasion of BC cells in the presence of CDDP chal...Continue Reading

References

Jun 15, 2011·International Urology and Nephrology·Yozo MitsuiMikio Igawa
Aug 21, 2012·Journal of Proteome Research·Nicole P ChappellThomas P Conrads
Oct 30, 2012·Neurotoxicology·Giada SantinMaria Grazia Bottone
May 9, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ryutaro KajiharaSeiji Inui
May 31, 2014·Cell Death & Disease·L GalluzziG Kroemer
Apr 22, 2015·Cancer Chemotherapy and Pharmacology·Jianli ChenHenry Simpkins
Jan 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xin YueXuelian He
Jun 28, 2016·Endocrine-related Cancer·Peng NingWei Li
Sep 24, 2016·Cytokine & Growth Factor Reviews·Shreeram C Nallar, Dhan V Kalvakolanu
Sep 27, 2016·International Journal of Molecular Medicine·Young-Chang ChoSayeon Cho
May 29, 2018·International Journal of Biological Sciences·Linna XieMin Zheng

❮ Previous
Next ❯

Citations

Jan 16, 2020·International Journal of Molecular Sciences·Consuelo BorrásJosé Viña

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.